Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


OctreoPharm Sciences GMBH

Radiolabeled diagnostics and treatments for neuroendocrine tumors

This article was originally published in Start Up

Executive Summary

The founders of OctreoPharm Sciences GMBH aim to commercialize new kinds of radiolabeled pharmaceuticals to treat all kinds of neuroendocrine tumors, plus matching diagnostics to improve physicians’ ability to detect and monitor these rare cancers. Beyond exclusive rights to relevant intellectual property, the founders’ backgrounds suggest they possess skills appropriate to the task



Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts